1. Home
  2. CVBF vs LQDA Comparison

CVBF vs LQDA Comparison

Compare CVBF & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVBF
  • LQDA
  • Stock Information
  • Founded
  • CVBF 1974
  • LQDA 2004
  • Country
  • CVBF United States
  • LQDA United States
  • Employees
  • CVBF N/A
  • LQDA N/A
  • Industry
  • CVBF Major Banks
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CVBF Finance
  • LQDA Health Care
  • Exchange
  • CVBF Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • CVBF 2.6B
  • LQDA 2.5B
  • IPO Year
  • CVBF N/A
  • LQDA 2018
  • Fundamental
  • Price
  • CVBF $20.21
  • LQDA $24.67
  • Analyst Decision
  • CVBF Buy
  • LQDA Strong Buy
  • Analyst Count
  • CVBF 4
  • LQDA 9
  • Target Price
  • CVBF $23.25
  • LQDA $32.11
  • AVG Volume (30 Days)
  • CVBF 630.8K
  • LQDA 2.2M
  • Earning Date
  • CVBF 10-22-2025
  • LQDA 11-12-2025
  • Dividend Yield
  • CVBF 4.09%
  • LQDA N/A
  • EPS Growth
  • CVBF N/A
  • LQDA N/A
  • EPS
  • CVBF 1.46
  • LQDA N/A
  • Revenue
  • CVBF $507,999,000.00
  • LQDA $19,322,000.00
  • Revenue This Year
  • CVBF N/A
  • LQDA $405.58
  • Revenue Next Year
  • CVBF $5.77
  • LQDA $373.93
  • P/E Ratio
  • CVBF $13.40
  • LQDA N/A
  • Revenue Growth
  • CVBF N/A
  • LQDA 30.20
  • 52 Week Low
  • CVBF $16.01
  • LQDA $9.68
  • 52 Week High
  • CVBF $24.58
  • LQDA $29.94
  • Technical
  • Relative Strength Index (RSI)
  • CVBF 54.64
  • LQDA 44.13
  • Support Level
  • CVBF $19.46
  • LQDA $25.34
  • Resistance Level
  • CVBF $20.53
  • LQDA $28.00
  • Average True Range (ATR)
  • CVBF 0.44
  • LQDA 1.28
  • MACD
  • CVBF -0.05
  • LQDA -0.74
  • Stochastic Oscillator
  • CVBF 60.48
  • LQDA 0.75

About CVBF CVB Financial Corporation

CVB Financial Corp is the holding company for Citizens Business Bank. Citizens Business Bank offers banking, lending, and investing services. It provides a full complement of lending products, including commercial, agribusiness, consumer, SBA, real estate, and construction loans, as well as equipment and vehicle leasing. Commercial products include lines of credit and other working capital financing, accounts receivable lending and letters of credit.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: